We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBP:NYSEInstalled Building Products, Inc. Analysis

Data as of 2026-05-19 - not real-time

$215.36

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Installed Building Products is navigating a turbulent quarter, with Q1 revenue contracting 3.5% year‑over‑year and earnings missing consensus estimates, driving the stock down roughly 25% to around $217. Technicals reinforce the downside pressure: the 20‑day SMA sits below the 50‑day SMA, RSI is at 35 (near oversold), and MACD remains bearish, while volatility has spiked above 100% over the past month. Despite these headwinds, the company’s fundamentals remain solid – a 38% ROE, 8.5% dividend yield with a modest 35% payout, and strong operating cash flow that comfortably covers debt service. However, the balance sheet is leveraged, with a debt‑to‑equity ratio exceeding 170%, and the market price of $215 is well above the DCF‑derived fair value of $126, suggesting an overvalued valuation at current levels. Recent analyst sentiment is mixed: RBC upgraded its outlook to sector‑perform, citing potential upside, while earnings disappointment has pulled sentiment down. The near‑term outlook is therefore cautious, but the underlying cash generation and dividend profile provide a foundation for medium‑term stability if the housing cycle improves.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Q1 earnings miss and revenue contraction
  • Bearish technical indicators (RSI 35, MACD negative)
  • Elevated volatility and high beta

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong ROE and cash flow generation
  • Dividend yield with sustainable payout
  • Potential upside from analyst upgrades and housing demand recovery

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term secular growth in residential construction and insulation demand
  • High leverage requiring careful debt management
  • Stable dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-3.50%
Profit Margin8.65%
P/E Ratio23.0
ROE38.36%
ROA11.14%
Debt/Equity176.87
P/B Ratio8.6
Op. Cash Flow$381.6M
Free Cash Flow$317.2M

Technical Analysis

TrendBearish
RSI35.2
Support$197.80
Resistance$322.96
MA 20$262.05
MA 50$271.70
MA 200$272.91
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$126.55
Target Price$249.17
Upside/Downside15.70%
GradeOvervalued
TypeBlend
Dividend Yield1.54%

Risk Assessment

Beta1.34
Volatility107.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.